Ethic Inc. Acquires 3,967 Shares of Globe Life Inc. $GL

Ethic Inc. increased its holdings in Globe Life Inc. (NYSE:GL) by 36.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,988 shares of the company’s stock after buying an additional 3,967 shares during the period. Ethic Inc.’s holdings in Globe Life were worth $2,678,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Jupiter Asset Management Ltd. bought a new position in Globe Life during the 4th quarter worth $2,073,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Globe Life by 34,786.0% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock valued at $123,345,000 after acquiring an additional 879,391 shares during the period. Strs Ohio lifted its position in shares of Globe Life by 213.7% during the 4th quarter. Strs Ohio now owns 21,907 shares of the company’s stock valued at $3,064,000 after acquiring an additional 14,924 shares during the period. Vanguard Group Inc. grew its holdings in shares of Globe Life by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after purchasing an additional 86,349 shares in the last quarter. Finally, Handelsbanken Fonder AB grew its holdings in shares of Globe Life by 23.1% during the 4th quarter. Handelsbanken Fonder AB now owns 75,235 shares of the company’s stock worth $10,522,000 after purchasing an additional 14,135 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors.

Insider Transactions at Globe Life

In other Globe Life news, Director Cheryl Alston sold 8,258 shares of the business’s stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the completion of the transaction, the director owned 16,621 shares of the company’s stock, valued at approximately $2,979,148.04. The trade was a 33.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO James Matthew Darden sold 50,000 shares of the business’s stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $182.43, for a total value of $9,121,500.00. Following the transaction, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at approximately $10,663,215.93. The trade was a 46.10% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 191,747 shares of company stock valued at $33,480,408. Company insiders own 2.11% of the company’s stock.

Globe Life Trading Up 1.8%

Shares of GL stock opened at $181.07 on Friday. The stock’s fifty day moving average price is $176.73 and its two-hundred day moving average price is $157.11. The company has a market cap of $13.92 billion, a PE ratio of 12.02 and a beta of 0.48. Globe Life Inc. has a fifty-two week low of $127.85 and a fifty-two week high of $191.55. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the business posted $3.05 EPS. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities analysts predict that Globe Life Inc. will post 15.71 EPS for the current fiscal year.

Globe Life declared that its Board of Directors has approved a stock buyback plan on Monday, August 10th that authorizes the company to repurchase $2.50 billion in shares. This repurchase authorization authorizes the company to buy up to 17.7% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its shares are undervalued.

Globe Life Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 annualized dividend and a yield of 0.7%. Globe Life’s dividend payout ratio (DPR) is 8.76%.

Analyst Upgrades and Downgrades

GL has been the topic of a number of recent analyst reports. TD Cowen raised their price target on Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. upped their price objective on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. Keefe, Bruyette & Woods reduced their price objective on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research note on Friday, July 24th. Jefferies Financial Group raised their target price on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a report on Friday, July 10th. Finally, Truist Financial boosted their target price on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $191.67.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.